MASS vs TXG
908 Devices Inc. - Common Stock · 10x Genomics, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | MASS | TXG |
|---|---|---|
| Price | $10.98 | $76.97 |
| Market Cap | $453.84M | $9.83B |
| P/E | 23.29 | — |
| P/B | 3.58 | 11.91 |
| P/S | 8.08 | 15.29 |
| ROE | 15.4% | -5.3% |
| Net Margin | 34.7% | -6.8% |
| Gross Margin | 50.6% | 69.1% |
| Revenue Growth | 17.7% | 5.2% |
| Dividend Yield | — | — |
| EPS | $0.47 | -$0.34 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.